A patient with myeloma who still has pure red cell aplasia despite the most intensive immune modulation

Leukemia Research

Volumn 21, Issue 4, 1997, Pages 353-354

  Orchard, Jenny ^a   Myint, Han ^a   Hamblin, Terry J ^a  

^a ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DOXORUBICIN; ERYTHROPOIETIN; IMMUNOMODULATING AGENT; VINCRISTINE;

ADULT; CASE REPORT; CLINICAL FEATURE; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOMODULATION; MALE; MYELOMA; PRIORITY JOURNAL; PURE RED CELL ANEMIA; SHORT SURVEY;

EID: 0030900373     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00028-3     Document Type: Article

References (6)

1. Resegotti I., Dolci C., Palestro G. & Peschle C. (1978) Paraproteinemic variety of pure red cell aplasia. Acta Haematol. 60, 227-232.
2. Alter R., Joshi S. S., Verdirame J. D. & Weisenburger D. D. (1990) Pure red cell aplasia associated with B cell lymphoma: demonstration on bone marrow colony inhibition by serum Ig. Leukemia Research 14, 279-288.
3. Masauzi N., Tanaku J. & Watanabe M. (1993) Primary Waldenstrom's Macroglobulinaemia associated with pure red cell aplasia in which Ts/c lymphocytes inhibiting erythroid precursors were detected. Rinsho Ketsueki 34, 355-361.
4. Karmockine M., Oskenhendler E., Leurez-Ville M., Jaccard A., Morenel F. & Hersans S. (1995) Persistent parvovirus B19 infection and pure red cell aplasia in Waldenstrom's Macroglobulinaemia. Successful treatment with high dose immunoglobulin. American Journal of Hematology 50, 227-228.
5. Williamson P. J., Oscier D. G., Bell A. J. & Hamblin T. J. (1991) Red cell aplasia in myelodysplastic syndrome. British Medical Journal 44, 431-432.
6. Copplestone J. A., Mufti G. J., Hamblin T. J. & Oscier D. G. (1986) Immunological abnormalities in myelodysplastic syndromes. II Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. British Journal of Haematology 63, 149-159.